Dosage Forms

Jun 14, 2018
By Pharmaceutical Technology Editors
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
Jun 13, 2018
By Pharmaceutical Technology Editors
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
Jun 08, 2018
By Pharmaceutical Technology Editors
MilliporeSigma targets emerging biotechs with US development center and global grants.
Jun 01, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Bosch Packaging Technology will introduce its newest R&D device for continuous oral solid dosage production at Achema 2018.
Jun 01, 2018
By Pharmaceutical Technology Editors
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
May 24, 2018
By Pharmaceutical Technology Editors
In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.
May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 16, 2018
By Pharmaceutical Technology Editors
Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
May 08, 2018
By Pharmaceutical Technology Editors
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
May 07, 2018
By Pharmaceutical Technology Editors
The data and analytics company reports on the anticipated uptake of Humira (adalimumab)‎‎ biosimilars in the EU once they are launched in 2018.
native1_300x100
lorem ipsum